Go Back

EnsoSleep PPG

ensodata.com

EnsoSleep PPG is an FDA-cleared, AI-powered solution for healthcare providers to accelerate the identification, diagnosis, and treatment of sleep-disordered breathing events. It analyzes photoplethysmogram (PPG) signals from pulse oximeters and provides tools for sleep study management and AI-assisted scoring. EnsoData also offers EnsoTherapy for predicting PAP therapy adherence.

Features
3/16
See all

Must Have

2 of 5

Comprehensive Educational eBooks

Data Export and Sharing

Daily Symptom and Usage Tracker

Personalized Care Plan Templates

Automated Reminders and Alerts

Other

1 of 11

Wearable and Device Integration

Community Support Forums

Resource Library

Mood and Fatigue Tracker

Appointment Calendar

Customizable Planner Templates

Gamification and Achievements

Multi-Platform Sync

Push Notifications

Accessibility Features

Night Mode

Pricing
Subscription
See all

EnsoSleep Study Management

$5.50 per use
  • Web-based study management
  • Viewing platform

EnsoSleep AI Scoring PSG

$18.00 per use
  • AI-powered scoring automation
  • PSGs

EnsoSleep AI Scoring HSAT

$9.50 per use
  • AI-powered scoring automation
  • HSATs
Rationale

EnsoSleep PPG is primarily a B2B solution for healthcare providers, focusing on AI-driven analysis of sleep study data for diagnosis and treatment. While it offers 'White Papers & eBooks' which could be considered educational resources, and it processes data from pulse oximeters (wearable integration), it lacks the direct patient-facing digital planner, daily trackers, personalized care plan templates, and automated reminders that are central to the ApneaCare Companion concept. The 'EnsoTherapy' product focuses on predicting therapy adherence for DMEs, not direct patient self-management tools.